OKL-3018

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameOKL-3018
Drug Alias Namecyclodextrin based therapeutics (Okklo Life Sciences)OKL-INF1 program (Okklo Life Sciences)OKL-3018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOkklo Life Sciences BV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOkklo Life Sciences BV
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A